Real-time enrollment status for this newly diagnosed glioblastoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 6:57 PM UTC
| NCT Number | NCT05864534 |
| Recruiting Status | Recruiting |
| Condition | Newly Diagnosed Glioblastoma |
| Phase | PHASE2 |
| Target Enrollment | 25 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Northwestern University |
| Last Updated on CT.gov | May 13, 2026 (May 13, 2026) |
As of July 18, 2026: Clinical trial NCT05864534 is currently recruiting participants. This phase2 study for newly diagnosed glioblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Northwestern University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05864534 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05864534 was last updated May 13, 2026 (May 13, 2026). HelloStudys verifies this status automatically.